Poliomyelitis  >>  Recombivax HB (hepatitis B vaccine recombinant)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Recombivax HB (hepatitis B vaccine recombinant) / Merck (MSD)
V419-006, NCT01340937 / 2011-004108-39: A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™

Completed
3
2808
NA
V419, PENTACEL™, Prevnar 13™, RotaTeq™, Recombivax HB vaccine
Merck Sharp & Dohme LLC, MCM Vaccines B.V.
Bacterial Infections, Virus Diseases
12/12
07/13
V419-005, NCT01337167 / 2011-004095-10: Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™

Completed
3
1473
NA
V419, DAPTACEL™, PedvaxHIB™, Prevnar 13™, RotaTeq™, V260, PENTACEL™, Recombivax HB vaccine, ActHIB™
Merck Sharp & Dohme LLC, MCM Vaccines B.V.
Bacterial Infections, Virus Diseases
05/13
05/13

Download Options